Lok Sabha Question No. 942 (UNSTARRED), answered on 2025-12-05
Subject: Implementation of the National Medical Devices Policy, 2023
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Shri Y S Avinash Reddy

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION NO. 942

TO BE ANSWERED ON THE 5 TH  DECEMBER, 2025

Implementation of the National Medical Devices Policy, 2023

## 942. Shri Y S Avinash Reddy:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) whether the measures have been taken to implement the National Medical Devices (NMD) Policy, 2023, if so, the details thereof;
- (b) whether any strategy has been framed to reduce import dependence by Seventy percent as laid down in the NMD Policy, if so, the details thereof; and
- (c) the details of financial allocations made in specific pursuit of said intended target?

## ANSWER

## THE MINISTER OF STATE IN THE  MINISTRY  OF  CHEMICALS  AND FERTILIZERS

(SMT. ANUPRIYA PATEL)

(a): The National Medical Devices Policy, 2023 aims to facilitate growth of the medical device sector  and  guide  its  development  through  a  set  of  strategies  across  six  key  areas,  namely, regulatory  streamlining,  enabling  infrastructure,  facilitating  research  and  development  and innovation,  attracting  investments  in  the  sector,  human  resource  development,  and  brand positioning and awareness creation. For implementation of the strategies envisaged under the National Medical Devices Policy, 2023, the Department of Pharmaceuticals is implementing several Central Sector schemes for the promotion of domestic medical device manufacturing, besides working closely with the stakeholders, within the Government, as well as the industry and academia. A portal has also been created to monitor action taken with the stakeholder Departments/Ministries as well as the central drugs regulator. As a result of these measures, the Indian medical device industry is growing rapidly in global competitiveness, and export of medical  devices  has  increased  form  US$  2.9  billion  in  FY2021-22  to  US$  4.1  billion  in FY2024-25.

- (b) and (c): Government of India has taken several measures to reduce import dependence, which includes the following:
- (i) Production Linked Incentive (PLI) scheme for promoting domestic manufacturing of Medical Devices : This scheme has a budgetary outlay of ₹3,420 crore and a five-year performance-linked  incentive  period  from  FY2022-23  to  FY2026-27.  Under  the scheme, selected companies are eligible for financial incentive for incremental sales of domestically  manufactured  medical  devices  in  the  radiotherapy,  imaging  device, anaesthesia,  cardio-respiratory  and  critical  care  and  implant  device  segments,  for  a

period  of  five  years.  As  of  September  2025,  22  greenfield  projects  have  been commissioned  and  production  has  started  for  55  products,  which  include  high-end medical devices on which the country has been highly import-dependent, such as linear accelerators,  machines  for  MRI  and  CT  scans  and  mammograms,  C-arm  X-ray machines,  MRI  coils  and  ultrasound  machines.  Till  September  2025,  cumulative eligible sales of ₹12,344.37 crore have been made under the scheme, including export sales worth ₹5,869.36 crore.

- (ii) Scheme for Promotion of Medical Devices Parks :  The scheme aims to provide easy access to world-class, common infrastructure facilities to medical device units set up in medical device parks. Under this scheme, three parks have been approved and are at an advanced  stage  of  development  in  Greater  Noida  (Uttar  Pradesh),  Ujjain  (Madhya Pradesh) and Kanchipuram (Tamil Nadu) districts. The total project cost of these is ₹871.11 crore, with Central assistance to the tune of ₹100 crore each for creation of common infrastructure facilities, which is expected to enhance industry's competitiveness  and  reduce  production  costs  through  optimisation  of  resources  and economies of scale. As of November 2025, out of a total of ₹300 crore for the three parks, a total of ₹180 crore stood released. Civil construction for the three parks is at the final stages. As of September 2025, 194 medical devices manufacturers have been allotted land in the three parks in a 298.58-acre area and 34 units have commenced construction of their plants.
- (iii) Scheme for Strengthening Medical Device Industry : This scheme has been launched on 8.11.2024 with a financial outlay of ₹500 crore. It aims to strengthen the medical device industry  by  providing  support  in  critical  areas,  including  manufacturing  of  key components and accessories, skill development, support for clinical studies, development  of  common  infrastructure,  and  industry  promotion  and  consists  of  the following sub-schemes:
- (1) Common Facilities for Medical Devices Clusters;
- (2) Marginal Investment Scheme for Reducing Import Dependence;
- (3) Capacity Building and Skill Development for Medical Devices;
- (4) Medical Device Clinical Studies Support Scheme; and
- (5) Medical Device Promotion Scheme.

******